FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1599-1600 November 21, 1996 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Until recently, cancer of the uterine cervix was a major cause of death among women of reproductive age in the United States.¹ In the 1960s, the pioneering work of Papanicolaou and Traut on the cytologic examination of exfoliated cells from the uterine cervix was recognized for its lifesaving potential to detect cancer, and the regular screening of women for cervical cancer — and, more important, its precursors — gradually became a routine part of medical practice.² Nonetheless, the practice of cervical cytologic screening (the Pap smear) owes its wide acceptance not so much to public recognition of its value, but . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Diakomanolis, E., Haidopoulos, D., Stefanidis, K. (2002). Treatment of High-Grade Vaginal Intraepithelial Neoplasia with Imiquimod Cream. NEJM 347: 374-374 [Full Text]  
• (1996). PAP TEST UNNECESSARY AFTER HYSTERECTOMY FOR BENIGN DISEASE. JWatch General 1996: 1-1 [Full Text]  
• (1996). No Need for Pap Smears after Hysterectomy. JWatch Women's Health 1996: 11-11 [Full Text]